News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Nord Investimentos Market update
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
This article first appeared on GuruFocus. Managerial Net Income: BRL1.14 billion in Q2 2026, up 9.5% year-over-year. Return on Equity (ROE): 70.9% at the end of June, the highest in company history, up 1.3 percentage points year-over-year. Operating Revenues: BRL1.5 billion in the quarter, …
TSSP Sub-Fund HoldCo, LLC and Alan Waxman have reported updated ownership positions in Caris Life Sciences, Inc. common stock, indicating they now hold less than 5% of the outstanding shares. As of June 30, 2026, their beneficial ownership stands at 2.4% and 2.6% respectively, …
This page provides live quotes and charts for Caris Life Sciences Inc. (CAI) stock, showing its current price at $22.69, a gain of 13.45%. It also includes sections for analyst ratings and earnings information, although specific data for these sections is not currently available …
Key Points Interested in Caris Life Sciences, Inc.? Here are five stocks we like better. Caris reported strong second-quarter growth: Revenue rose 45% year over year to $263.7 million, while clinical cases increased 18% to approximately 59,200. Adjusted EBITDA improved to $55.7 million from …
Eleven analysts covering Caris Life Sciences (NASDAQ:CAI) have given it a consensus "Hold" rating, with an average 12-month price target of $26.11. The company's shares recently opened at $16.32, near its 12-month low, and the company has authorized a $100 million share buyback program. …
Renaissance Technologies LLC increased its stake in Caris Life Sciences, Inc. by 36.4% in the first quarter, acquiring an additional 120,000 shares to own a total of 449,900 shares valued at $8.0 million. Insider transactions also showed significant purchases by directors Jeff L. Vacirca …
This article reports on a Form 144 SEC filing by Caris Life Sciences, Inc. (CAI) on August 3, 2026. The filing details a proposed sale of 20,000 shares of common stock with an aggregate market value of $325,000.00, acquired through a stock option exercise, …
CaixaBank has reorganised its wealth management and asset management businesses, which serve private banking, wealth and institutional clients. The overhaul will see Juan Llamas become head of CaixaBank wealth management, taking over from Belén Martín. Martín is moving to CaixaBank CIB as managing director …
Sharemaestro market context Trend signal active 52 weeks +27.6% · Next-week setup negative 20.2%Rock Springs Capital Management LP reduced its stake in Caris Life Sciences, Inc. (NASDAQ:CAI) by 18.1% in the first quarter, selling 124,500 shares but still owning 563,000 shares valued at $10.066 million. Despite this, several other institutional investors increased their holdings. The company also …
Company Logo Dublin, July 21, 2026 (GLOBE NEWSWIRE) -- The "Biomarker Collaboration and Licensing Deals 2016-2026" has been added to ResearchAndMarkets.com's offering. This report provides a comprehensive and structured analysis of 590+ biomarker collaboration and licensing deals, delivering a clear and evidence-based view of …
Search by ticker symbol or company name and select a result to open its chart.